Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Rating) saw a large increase in short interest in May. As of May 15th, there was short interest totalling 310,400 shares, an increase of 378.3% from the April 30th total of 64,900 shares. Based on an average daily trading volume, of 1,897,300 shares, the short-interest ratio is presently 0.2 days.
Bayer Aktiengesellschaft Price Performance
BAYRY traded down $0.18 on Friday, hitting $14.31. 740,021 shares of the company were exchanged, compared to its average volume of 788,487. The firm has a fifty day simple moving average of $15.79 and a two-hundred day simple moving average of $14.98. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.16 and a quick ratio of 0.77. Bayer Aktiengesellschaft has a 12 month low of $11.41 and a 12 month high of $18.01.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Rating) last released its quarterly earnings results on Thursday, May 11th. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.24. Bayer Aktiengesellschaft had a return on equity of 18.53% and a net margin of 6.06%. The company had revenue of $15.44 billion for the quarter, compared to analyst estimates of $15.76 billion. Equities research analysts forecast that Bayer Aktiengesellschaft will post 1.88 earnings per share for the current year.
Bayer Aktiengesellschaft Increases Dividend
Bayer Aktiengesellschaft Company Profile
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents.
- Get a free copy of the StockNews.com research report on Bayer Aktiengesellschaft (BAYRY)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.